Top Markets
#1 Akedo Akedo +59.38%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.41%
#4 Velvet Velvet +39.92%
#5 Black Phoenix Black Phoenix +34.56%
#6 τemplar τemplar +23.53%
#7 Ribbita by Virtuals Ribbita by Virtuals +17.77%
#8 Cross Cross +15.77%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.57%
#10 Bitway Bitway +15.46%
Coin of the day
Akedo Akedo
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Geffen Residence & Renewal Ltd Geffen Residence & Renewal Ltd

Geffen Residence & Renewal Ltd

GEFR
Rang in Aktien #38275
Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis... Geffen Residence & Renewal Ltd, previously known as Cannomed Medical Cannabis Industries Ltd, is a company with a dual focus based in Tel Aviv-Yafo, Israel, established in 1999. It plays a significant role in the Israeli medical cannabis market, overseeing the growth, manufacturing, storage, distribution, and retail of these products. Additionally, the company operates a chain of pharmacies that offer a wide array of merchandise. These retail outlets provide personal care items, cosmetics, and various convenience goods. Their pharmaceutical offerings include prescription and over-the-counter medications, alongside natural health products, vitamins, and supplements. The pharmacies also stock first-aid supplies like plasters and bandages, as well as health monitoring devices such as thermometers and humidifiers.
Aktienkurs
$0.26456612
Marktkapitalisierung
$1.09M
Veränderung (1 Tag)
1.24%
Veränderung (1 Jahr)
13.83%
Land
IL
Handel Geffen Residence & Renewal Ltd (GEFR)

Kategorie

Healthcare
Kursverlauf für Geffen Residence & Renewal Ltd (GEFR)
Höchster Schlusskurs: $0.26 am 2026-08-01

Niedrigster Schlusskurs: $2.55 am 2011-05-01
Kursverlauf der Aktie von Geffen Residence & Renewal Ltd von 2011 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 4.46%
2025 28.60%
2024 38.66%
2023 -23.00%
2022 44.43%
2021 -64.31%
2020 -52.65%
2019 -8.44%
2018 118.40%
2017 -22.24%
2016 -14.06%
2015 2.88%
2014 -22.15%
2013 -20.61%
2012 -45.00%
2011 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 29.45%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE